Kieran Cody, MD
Orthopedic Surgery · Doylestown, PANPI 1689653677
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,172 of the $9,881 with a category attached, or 72.6%. Stryker accounts for 83.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $3,571 and has fallen 57.3% since, to $1,525 in 2025.
Across 185 payments — averaging $53.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Pacira Therapeutics, Inc.$794
- Zimmer Biomet$412
- Smith+Nephew$119
- Johnson & Johnson$107
- Paladin Technology Solutions$53
- plus $159 from 5 others
What the payments were for
- Travel & lodging$2,70927%
- Food & beverage$7,17273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 141 | $8,237 |
| Pacira Therapeutics, Inc. | 21 | $794 |
| Zimmer Biomet | 7 | $412 |
| Smith+Nephew | 5 | $119 |
| Johnson & Johnson | 2 | $107 |
| Paladin Technology Solutions | 1 | $53 |
| Catalyst Orthoscience | 2 | $51 |
| Liberty Surgical Inc. | 2 | $48 |
| AstraZeneca | 2 | $25 |
| Sanara Medtech Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$3,257
- REUNION$612
- Zilretta$353
- TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$213
- AEQUALIS PERFORM$149
- GAMMA$130
- PANGEA$126
- T2$122
- TORNIER PERFORM REVERSED GLENOID$110
- Persona$107
How this compares
$9,881 in reported general payments places this provider in the 80th percentile of 43 orthopedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 184 | $349 |
| Celecoxib | 14 | $227 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Doylestown
- Charles BurrowsDoylestown$971
- James BradleyPittsburgh$5.2M
- Carl HasselmanPittsburgh$719K
- Richard McGoughPittsburgh$261K
- Vincent SilvaggioPittsburgh$179K
- Stephen ThomasMoon Township$30K
- Patrick SmithPittsburgh$20K
- Jennifer BidoPhiladelphia$10K
- Alex KlinePittsburgh$8K
- Trenton GausePittsburgh$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.